These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34305872)

  • 1. Continual Decline in Azole Susceptibility Rates in
    Wang Y; Fan X; Wang H; Kudinha T; Mei YN; Ni F; Pan YH; Gao LM; Xu H; Kong HS; Yang Q; Wang WP; Xi HY; Luo YP; Ye LY; Xiao M;
    Front Microbiol; 2021; 12():702839. PubMed ID: 34305872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study.
    Xiao M; Sun ZY; Kang M; Guo DW; Liao K; Chen SC; Kong F; Fan X; Cheng JW; Hou X; Zhou ML; Li Y; Yu SY; Huang JJ; Wang H; Xu YC;
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notable Increasing Trend in Azole Non-susceptible
    Fan X; Xiao M; Liao K; Kudinha T; Wang H; Zhang L; Hou X; Kong F; Xu YC
    Front Microbiol; 2017; 8():464. PubMed ID: 28382028
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence and Antifungal Susceptibility of Pathogenic Yeasts in China: A 10-Year Retrospective Study in a Teaching Hospital.
    Song Y; Chen X; Yan Y; Wan Z; Liu W; Li R
    Front Microbiol; 2020; 11():1401. PubMed ID: 32719663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.
    Wang H; Xiao M; Chen SC; Kong F; Sun ZY; Liao K; Lu J; Shao HF; Yan Y; Fan H; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Xu YC
    J Clin Microbiol; 2012 Dec; 50(12):3952-9. PubMed ID: 23035204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of
    Chen J; Hu N; Xu H; Liu Q; Yu X; Zhang Y; Huang Y; Tan J; Huang X; Zeng L
    Front Cell Infect Microbiol; 2021; 11():721439. PubMed ID: 34604110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China.
    Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC
    Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
    Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study.
    Xiao M; Chen SC; Kong F; Xu XL; Yan L; Kong HS; Fan X; Hou X; Cheng JW; Zhou ML; Li Y; Yu SY; Huang JJ; Zhang G; Yang Y; Zhang JJ; Duan SM; Kang W; Wang H; Xu YC
    J Infect Dis; 2020 Mar; 221(Suppl 2):S139-S147. PubMed ID: 32176789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
    Wang H; Xu YC; Hsueh PR
    Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends towards lower azole susceptibility among 200 Candida tropicalis bloodstream isolates from Brazilian medical centres.
    Favarello LM; Nucci M; Queiroz-Telles F; Guimarães T; Salles MJ; Sukiennik TCT; da Matta DA; Melo ASA; Colombo AL
    J Glob Antimicrob Resist; 2021 Jun; 25():199-201. PubMed ID: 33812048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
    Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
    J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression.
    Wang D; An N; Yang Y; Yang X; Fan Y; Feng J
    Antimicrob Resist Infect Control; 2021 Mar; 10(1):54. PubMed ID: 33722286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of fluconazole resistant
    Fan X; Tsui CKM; Chen X; Wang P; Liu ZJ; Yang CX
    Front Microbiol; 2023; 14():1125241. PubMed ID: 36937265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azole resistance in Candida from animals calls for the One Health approach to tackle the emergence of antimicrobial resistance.
    Castelo-Branco DSCM; Paiva MAN; Teixeira CEC; Caetano ÉP; Guedes GMM; Cordeiro RA; Brilhante RSN; Rocha MFG; Sidrim JJC
    Med Mycol; 2020 Oct; 58(7):896-905. PubMed ID: 31950176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.